By: IPP Bureau
Last updated : November 25, 2025 7:06 pm
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market
GE HealthCare is all set to solidify its position as a leading provider of comprehensive, cloud-first imaging solutions, bridging the gap between hospital and outpatient care while driving the next wave of AI-enabled healthcare innovation.
The company has announced a landmark agreement to acquire Intelerad, a leading medical imaging software provider, in a $2.3 billion all-cash deal. The acquisition aligns with its goal to triple cloud-based product offerings by 2028.
Intelerad is a recognized leader in radiology and cardiology imaging software, with a strong presence in outpatient and ambulatory care settings. Its cloud-first platform complements GE HealthCare’s dominant hospital-based imaging business, creating an integrated, AI-enabled imaging portfolio spanning both inpatient and outpatient care networks—from large academic medical centers to expanding ambulatory clinics.
"As hospital and outpatient care providers face rising imaging demand, they need simpler, unified workflows,” said Peter Arduini, President and CEO of GE HealthCare. “This acquisition expands our cloud-enabled and intelligent solutions, helping care teams improve efficiency, enhance patient outcomes, and deliver precision care globally.”
Roland Rott, President and CEO of Imaging at GE HealthCare, added, “Intelerad is a pioneer in cloud-based imaging. By combining GE HealthCare’s global medical device and AI expertise with Intelerad’s enterprise cloud software, we can drive digital innovation and simplify complex workflows across the healthcare industry.”
Intelerad CEO Jordan Bazinsky highlighted the growth potential, stating, “Joining GE HealthCare opens a new chapter for Intelerad. Their global scale and hospital system relationships will accelerate the adoption of our connected imaging software, bringing more AI-enabled solutions to healthcare providers.”
The deal accelerates GE HealthCare’s digital transformation, expanding its reach into outpatient care and enterprise imaging—a $2 billion-plus growth market projected to grow in the double digits. Intelerad’s recurring revenue model bolsters GE HealthCare’s shift toward SaaS, with first-year revenues expected at $270 million, 90% recurring, and an EBITDA margin above 30%.
The acquisition is projected to be immediately accretive to top-line growth and Adjusted EBIT, with a high-single-digit return on invested capital by year five.
The acquisition is expected to close in the first half of 2026, pending regulatory approvals.
GE HealthCare will fund the transaction through cash and debt financing. Evercore and Sidley Austin LLP advised GE HealthCare, while UBS Investment Bank and Skadden, Arps, Slate, Meagher & Flom LLP advised Intelerad.